← Feed

Daly Jason B.

SEC Form 4 insider
EVP, Chief Legal Officer · Amneal Pharmaceuticals, Inc. ($AMRX)
1 thesis · first seen Aug 13, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$AMRXSEC Form 4bearish
Daly Jason B. · EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc. · 4h agono track record yet
Sold 216,613 @ $17.41 avg · $3,771,050 · 2026-08-11

Form 4: Daly Jason B. sold AMRX

Daly Jason B. (EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc.) reported an open-market sale of 216,613 shares of AMRX at an average $17.41, roughly $3,771,050, in a Form 4 filed 2026-08-13.

View filing on SEC.gov →

End of results.